News and blog

The Appeal highlights neglect by BlueMountain Capital’s prison healthcare company Corizon

February 11, 2019

Late last week criminal justice-focused publication The Appeal ran a long story on neglect by Corizon, the prison healthcare giant owned by private equity and hedge fund firm BlueMountain Capital.

The Appeal, Feb 8, 2019: “Corizon, the prison healthcare giant, stumbles again”

The article highlighted Corizon’s recent loss of a contract to provide healthcare services at Arizona Department of Corrections facilities and allegations of patient neglect:

“By the time Walter Jordan began radiation therapy on July 21, 2017, his skin cancer had already eaten through his skull and spread to his brain, according to a doctor who later reviewed the medical files. Jordan, who was incarcerated in a state prison in Florence, Arizona, had squamous cell cancer, a type of skin cancer that has a more than 90 percent cure rate, wrote the doctor, Todd Wilcox.

About a week before his death, Jordan wrote to the U.S. District Court. ‘ADOC [Arizona Department of Corrections] and Corizon delayed treating my cancer. Now because of there delay, I may be luckey to be alive for 30 days.’”

In 2017 BlueMountain Capital Management, a New York-based hedge fund, became the majority shareholder in Corizon, replacing the Chicago-based private equity firm Beecken Petty O’Keefe & Company, which retains a small stake in Corizon.

“If you hear the stories of these families and the pain that they have suffered, [BlueMountain] should be ashamed they’re investing,” said Tiera Rainey, a program coordinator with the American Friends Service Committee-Arizona, a prisoner advocacy organization. “Every dollar you’re making off of that investment is coming from human suffering.”

Full article available here (link).

Sign up to our newsletter to receive news and updates from PESP

Click here